Clinical Trial Update: Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing optimization of cardiac resynchronization therapy using ventricle-to-ventricle timing in heart failure patients has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy device

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2015-09-25